Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -43.70%
March 31, 2026 20.22%
December 31, 2025 37.47%
September 30, 2025 34.24%
June 30, 2025 17.60%
March 31, 2025 19.10%
December 31, 2024 24.06%
September 30, 2024 22.87%
June 30, 2024 19.03%
March 31, 2024 19.32%
December 31, 2023 28.68%
September 30, 2023 28.15%
June 30, 2023 29.78%
March 31, 2023 30.10%
December 31, 2022 19.30%
September 30, 2022 25.58%
June 30, 2022 28.15%
March 31, 2022 10.31%
December 31, 2021 21.30%
September 30, 2021 8.59%
June 30, 2021 25.24%
March 31, 2021 10.54%
December 31, 2020 -246.8%
September 30, 2020 30.41%
June 30, 2020 -38.34%
Date Value
March 31, 2020 28.53%
December 31, 2019 25.57%
September 30, 2019 13.63%
June 30, 2019 32.64%
March 31, 2019 -17.59%
December 31, 2018 27.62%
September 30, 2018 25.75%
June 30, 2018 27.62%
March 31, 2018 29.10%
December 31, 2017 25.30%
September 30, 2017 21.31%
June 30, 2017 22.97%
March 31, 2017 13.01%
December 31, 2016 -17.39%
September 30, 2016 6.40%
June 30, 2016 11.48%
March 31, 2016 11.72%
December 31, 2015 -26.36%
September 30, 2015 14.08%
June 30, 2015 -30.95%
March 31, 2015 -7.76%
December 31, 2014 45.29%
September 30, 2014 -27.84%
June 30, 2014 -202.6%
March 31, 2014 57.83%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. 54.51%
Edwards Lifesciences Corp. 78.09%
Intuitive Surgical, Inc. 68.35%
Kewaunee Scientific Corp. 29.61%
STAAR Surgical Co. 71.98%

Gross Profit Margin (Quarterly) Related Metrics